London, ON - Defibrillation-threshold (DFT) testing performed on a routine basis at ICD implantation is unlikely to significantly affect one- or five-year mortality, according to a statistical ...
Dallas, TX - Antiarrhythmic agents used with today's implantable cardioverter defibrillators (ICDs), particularly amiodarone, don't raise successful-shock energy requirements enough to make ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Routine defibrillation testing appears to be safe, but does not improve outcomes in patients ...
Defibrillation testing of implantable cardioverter–defibrillators (ICDs) does not improve outcomes compared with device implantation without testing and, therefore, “defibrillation testing during ...